Preliminary results from subsets of patients (pts) with advanced gastric cancer (GC) and esophageal carcinoma (EC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb) Conference Paper uri icon

authors

  • Desai, J
  • Millward, M
  • Chao, Y
  • Gan, H
  • Voskoboynik, M
  • Markman, B
  • Townsend, A
  • Atkinson, V
  • Zhu, A
  • Song, J
  • Qi, Q
  • Kang, A
  • Deva, S

publication date

  • September 1, 2017